Dergiler / Retina-Vitreus / 2015 / Cilt: 23 - Sayı: 0

Diyabetik Retinopati Kliniği

Sayfa
28–31
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

BÜRÜMCEK, E. (2015). Diyabetik Retinopati Kliniği. Retina-Vitreus, Cilt: 23 - Sayı: 0, 28–31. https://ajindex.com/articles/308034

Kaynakça (9)

  1. Klein R, Knudtson MD, Lee KE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinop- athy in persons with type 1 diabetes. Ophthalmology 2008;115:1859-68.
  2. Hirai FE, Tielsch JM, Klein BE, et al.Ten-year change in vision-related quality of life in type 1 diabetes: Wisconsin epidemiologic study of dia- betic retinopathy. Ophthalmology 2011;118:353-8. Satman İ ve TURDEP-II Çalışma Grubu. Türkiyede Diabetes Mellitus Prevalans Çalışması-II: İstanbul Üniversitesi İstanbul Tıp Fakültesi İç Hastalıkları Anabilim Dalı Endokrinoloji ve Metabo-lizma Hastalıkları Bilim Dalı, İstanbul 2010:2. Hirai FE, Moss SE, Klein BE, et al. Relationship of glycemic control, ex- ogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy(WESDR). Diabetes Care 2008;31:493-7. DCCT. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabe- tes Care 1999;22:99-111.
  3. Klein R, Klein BE, Moss SE, et al. Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med 1994;154:2169-78.
  4. Fong DS, Contreras R. Glitazone use associated with diabetic macular edema.Am J Ophthalmol 2009;147:583-6.
  5. Liu Y, Wang M, Morris AD, et al. Glycemic exposure and blood pressure influencing progression and remission of diabetic retinopathy: a longitu- dinal cohort study in GoDARTS. Diabetes Care 2013;36:3979-84.
  6. Virgili G, Menchini F, Dimastrogiovanni AF, et al. Optical coherence to- mography versus stereoscopic fundus photography or biomicroscopy for diagnosing diabetic macular edema: a systematic review. Invest Ophthal- mol Vis Sci 2007;48:4963-73.
  7. Nunes S, Pires I, Rosa A, et al. Microaneurysm turnover is a biomark-er for diabetic retinopathy progression to clinically significant macular edema: findings for type 2 diabetics with nonproliferative retinopathy. Ophthalmologica 2009;223:292-7.
  8. Silva PS, Cavallerano JD, Sun JK, et al. Peripheral lesions identified by mydriatic ultrawide field imaging: distribution and potential impact on diabetic retinopathy severity. Ophthalmology 2013;120:2587-95. Newman DK. Surgical management of the late complications of prolifera-tive diabetic retinopathy Eye (Lond) 2010;24:441-9.
  9. Crawford TN, Alfar